Journal of Pregnancy / 2014 / Article / Tab 4

Clinical Study

Revisiting the Role of First Trimester Homocysteine as an Index of Maternal and Fetal Outcome

Table 4

Homocysteine levels with reference to fetal outcome of present pregnancy.

No fetal congenital malformation
( = 88)
Fetal congenital malformation
( = 2)
valueStatistical test used

Serum homocysteine ( mol/L)14.56 ± 8.012.07 ± 1.750.6621Mann-Whitney test

No pregnancy loss
( = 82)
Pregnancy loss
( = 8)

Serum homocysteine ( mol/L)13.51 ± 7.4724.65 ± 4.510.0002 ** Mann-Whitney test

Clear amniotic fluid
( = 67)
Meconium stained amniotic fluid
( = 17)

Serum homocysteine ( mol/L)12.52 ± 6.9418.43 ± 8.480.0037 * Mann-Whitney test

No oligohydramnios
( = 66)
Oligohydramnios
( = 18)

Serum homocysteine ( mol/L)12.58 ± 7.0120.02 ± 7.92<0.0001 ** Mann-Whitney test

Birth weight
≥2500 gm
( = 73)
Birth weight
<2500 gm
( = 11)

Serum homocysteine ( mol/L)12.35 ± 5.6423.22 ± 12.320.0224 * Unpaired -test—Welch correction

significant.
** highly significant.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.